SDP ONCOLOGY

Serial Number 79295445
Registration 6331240
404

Registration Progress

Application Filed
Aug 6, 2020
Under Examination
Approved for Publication
Feb 9, 2021
Published for Opposition
Feb 9, 2021
Registered
Apr 27, 2021

Trademark Image

SDP ONCOLOGY

Basic Information

Serial Number
79295445
Registration Number
6331240
Filing Date
August 6, 2020
Registration Date
April 27, 2021
Published for Opposition
February 9, 2021
Cancellation Date
January 3, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
404
Status Date
Apr 5, 2024

Rights Holder

Sumitomo Dainippon Pharma Co., Ltd.

03
Address
6-8, Doshomachi 2-chome,
Chuo-ku, Osaka-shi Osaka 541-0045
JP

Ownership History

Sumitomo Dainippon Pharma Co., Ltd.

Original Applicant
03
JP

Sumitomo Dainippon Pharma Co., Ltd.

Owner at Publication
03
JP

Sumitomo Dainippon Pharma Co., Ltd.

Original Registrant
03
JP

Legal Representation

Attorney
Rebeccah Gan

USPTO Deadlines

Next Deadline
620 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-04-27)
Due Date
April 27, 2027
Grace Period Ends
October 27, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Jan 21, 2024 DENC E NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Loading...
Jan 21, 2024 DETH P DEATH OF INTERNATIONAL REGISTRATION Loading...
Aug 29, 2021 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Aug 12, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Aug 12, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 27, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 27, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 9, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 9, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 20, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 6, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 6, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 6, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jan 6, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 6, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 17, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 16, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 16, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 7, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Nov 16, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Nov 16, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Oct 29, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Oct 28, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 24, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 20, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 20, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 16, 2020 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Oct 8, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Additional Information

Pseudo Mark
SUMITOMO DAINIPPON PHARMA ONCOLOGY

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ONCOLOGY"